Browse the corpus

The human body is designed to fight against infections and kill cancer cells. An essential feature of the human immune system is recognizing and distinguishing between its cells (known as 'self') and foreign cells like bacteria and viruses (known as 'non-self'). Every cell has proteins related to their origin and functioning environment, called antigens, that differentiate between self and non-self by the immune system. As a component of the immune system, antibodies or immunoglobulins are proteins produced by immune cells called B Lymphocytes, which eventually convert into plasma cells. These antibodies are mainly produced during exposure to infection or by binding to antigens; their job is to neutralize or eliminate non-self-entities entering the body. Antibodies are also produced via vaccination by either exposure to killed antigens or direct inoculation of already formed antibodies in vitro. The immune system's failure to recognize 'self' is called autoimmunity, in which the immune system attacks some human body tissues and destroys them. In autoimmunity, there is the formation of antibodies against self-antigens called autoantibodies. These autoantibodies form against one type of cell to which they bind and destroy. Antineutrophil cytoplasmic antibodies (ANCAs) are specific antibodies formed against cytoplasmic granules (antigens) of polymorphonuclear neutrophil granulocytes (PMNs).[1] These autoantibodies are present in ANCA-associated small-vessel vasculitides. The applied use of ANCA lab testing, which detects ANCA autoantibodies, is used to diagnose several vasculitis diseases, primarily pauci-immune small vessel vasculitides granulomatosis with polyangiitis (GPA, previously called Wegener granulomatosis), microscopic polyangiitis (MPA), and to lesser extent eosinophilic granulomatosis with polyangiitis (eg, Churg-Strauss syndrome) and anti-Goodpasture disease.[1][2]

Neutrophils are the most abundant leukocyte type, comprising 50% to 75% of the white blood cell population. About 1800 to 8000 neutrophils are normally present per microliter of blood; their number can increase 10-fold under infectious conditions. Neutrophils contain 2 main types of granules: 1) peroxidase-positive (azurophilic), and 2) peroxidase-negative. Both ANCA-myeloperoxidase (MPO) and ANCA-proteinase 3 (PR3) are enzymes present in peroxidase-positive granules, and MPO is the most prevalent granular protein. PR3 is important for serving as a hematopoietic regulator and has apoptosis-inducing capabilities. Some less specific ANCA antigens include cathepsin G, lactoferrin, elastase, defensin, α-enolase, moesin, leukocidin, bactericidal-permeability-increasing protein, and lysosome-associated membrane glycoprotein 2. The pathogenicity of these antigens is thought to be low.[3] ANCA serology is positive in about 90% of GPA and MPO cases, while it is positive in about 30% of eosinophilic granulomatosis with polyangiitis cases.[4] Anti-PR3 antibodies are about 90% sensitive for GPA.[5][6] Although sensitive and specific for GPA, ANCA positivity has also been noted in 15% to 20% of patients with systemic lupus erythematosus, especially those with lupus nephritis.[7] C-ANCA (a cytoplasmic antineutrophilic nuclear antibody with extranuclear cytoplasmic staining) is 90% PR3 reactive and 10% MPO reactive; P-ANCA (a perinuclear antineutrophilic nuclear antibody with staining around the nucleus) is 90% MPO reactive and 10% PR3 reactive.[8] Small vessel damage caused by ANCA occurs when these autoantibodies bind to granules in neutrophils. The mechanism of pathogenesis is given below: Neutrophils and monocytes are activated by ANCA. The alternative complement pathway is subsequently activated. Neutrophils migrate through blood vessel walls, and inflammatory mediators are released. Chemoattractants are released, and more inflammatory mediators are recruited. Inflammation, apoptosis, necrosis, and damage to small blood vessel walls occur.[9][10] Drugs Linked to ANCA–Associated Vasculitis

The alternative complement pathway is subsequently activated. Neutrophils migrate through blood vessel walls, and inflammatory mediators are released. Chemoattractants are released, and more inflammatory mediators are recruited. Inflammation, apoptosis, necrosis, and damage to small blood vessel walls occur.[9][10] Drugs Linked to ANCA–Associated Vasculitis Medications can induce an ANCA-associated vasculitis, usually manifesting as rapidly progressive glomerulonephritis. Specifically, a high MPO titer is common. Levamisole, which is often found in contaminated cocaine, can cause the elevation of both anti-MPO and anti-PR3 antibodies, along with other autoantibodies, skin lesions, and arthralgias. Treatment is the same as other ANCA-associated rapidly progressive glomerulonephritis cases—possibly with shorter induction. The most common offending medications include these: Hydralazine Propylthiouracil and methimazole Allopurinol Sulfasalazine Minocycline Penicillamine Rifampicin Aminoguanidine Sofosbuvir Anti-tumor necrosis factor-alpha therapy for rheumatoid arthritis and ankylosing spondylitis [11]

Care coordination is pivotal in ensuring seamless and efficient patient care. Physicians, advanced clinicians, nurses, pharmacists, and other healthcare professionals must work together to streamline the patient's journey, from diagnosis through treatment and follow-up. This coordination minimizes errors, reduces delays, and enhances patient safety, ultimately leading to improved outcomes and patient-centered care.